Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Self-administered Parenteral Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4680636
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Self-administered Parenteral market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Self-administered Parenteral market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Self-administered Parenteral market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self-administered Parenteral market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self-administered Parenteral market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Self-administered Parenteral market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Self-administered Parenteral
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Self-administered Parenteral market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton, Dickinson and Company, scPharmaceuticals, Harro Hofliger, Owen Mumford, Haselmeier, Stevanato Group, Ypsomed AG, Solteam Group, AstraZeneca, Enable lnjections, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Self-administered Parenteral market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pre-filled Syringes
Autoinjectors
Pen Injectors
Others
Market segment by Application
Pharmacy
Online Sales
Other
Major players covered
Becton, Dickinson and Company
scPharmaceuticals
Harro Hofliger
Owen Mumford
Haselmeier
Stevanato Group
Ypsomed AG
Solteam Group
AstraZeneca
Enable lnjections
CCBio
Phillips-Medisize Corporation
Sorrel Medical
Krontec Healthcare
Subcuject Aps
Ascendia Pharmaceuticals
West Pharmaceutical Services, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Self-administered Parenteral product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self-administered Parenteral, with price, sales quantity, revenue, and global market share of Self-administered Parenteral from 2021 to 2026.
Chapter 3, the Self-administered Parenteral competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self-administered Parenteral breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Self-administered Parenteral market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self-administered Parenteral.
Chapter 14 and 15, to describe Self-administered Parenteral sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Self-administered Parenteral Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Pre-filled Syringes
    • 1.3.3 Autoinjectors
    • 1.3.4 Pen Injectors
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Self-administered Parenteral Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmacy
    • 1.4.3 Online Sales
    • 1.4.4 Other
  • 1.5 Global Self-administered Parenteral Market Size & Forecast
    • 1.5.1 Global Self-administered Parenteral Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Self-administered Parenteral Sales Quantity (2021-2032)
    • 1.5.3 Global Self-administered Parenteral Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Becton, Dickinson and Company
    • 2.1.1 Becton, Dickinson and Company Details
    • 2.1.2 Becton, Dickinson and Company Major Business
    • 2.1.3 Becton, Dickinson and Company Self-administered Parenteral Product and Services
    • 2.1.4 Becton, Dickinson and Company Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Becton, Dickinson and Company Recent Developments/Updates
  • 2.2 scPharmaceuticals
    • 2.2.1 scPharmaceuticals Details
    • 2.2.2 scPharmaceuticals Major Business
    • 2.2.3 scPharmaceuticals Self-administered Parenteral Product and Services
    • 2.2.4 scPharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 scPharmaceuticals Recent Developments/Updates
  • 2.3 Harro Hofliger
    • 2.3.1 Harro Hofliger Details
    • 2.3.2 Harro Hofliger Major Business
    • 2.3.3 Harro Hofliger Self-administered Parenteral Product and Services
    • 2.3.4 Harro Hofliger Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Harro Hofliger Recent Developments/Updates
  • 2.4 Owen Mumford
    • 2.4.1 Owen Mumford Details
    • 2.4.2 Owen Mumford Major Business
    • 2.4.3 Owen Mumford Self-administered Parenteral Product and Services
    • 2.4.4 Owen Mumford Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Owen Mumford Recent Developments/Updates
  • 2.5 Haselmeier
    • 2.5.1 Haselmeier Details
    • 2.5.2 Haselmeier Major Business
    • 2.5.3 Haselmeier Self-administered Parenteral Product and Services
    • 2.5.4 Haselmeier Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Haselmeier Recent Developments/Updates
  • 2.6 Stevanato Group
    • 2.6.1 Stevanato Group Details
    • 2.6.2 Stevanato Group Major Business
    • 2.6.3 Stevanato Group Self-administered Parenteral Product and Services
    • 2.6.4 Stevanato Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Stevanato Group Recent Developments/Updates
  • 2.7 Ypsomed AG
    • 2.7.1 Ypsomed AG Details
    • 2.7.2 Ypsomed AG Major Business
    • 2.7.3 Ypsomed AG Self-administered Parenteral Product and Services
    • 2.7.4 Ypsomed AG Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ypsomed AG Recent Developments/Updates
  • 2.8 Solteam Group
    • 2.8.1 Solteam Group Details
    • 2.8.2 Solteam Group Major Business
    • 2.8.3 Solteam Group Self-administered Parenteral Product and Services
    • 2.8.4 Solteam Group Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Solteam Group Recent Developments/Updates
  • 2.9 AstraZeneca
    • 2.9.1 AstraZeneca Details
    • 2.9.2 AstraZeneca Major Business
    • 2.9.3 AstraZeneca Self-administered Parenteral Product and Services
    • 2.9.4 AstraZeneca Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AstraZeneca Recent Developments/Updates
  • 2.10 Enable lnjections
    • 2.10.1 Enable lnjections Details
    • 2.10.2 Enable lnjections Major Business
    • 2.10.3 Enable lnjections Self-administered Parenteral Product and Services
    • 2.10.4 Enable lnjections Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Enable lnjections Recent Developments/Updates
  • 2.11 CCBio
    • 2.11.1 CCBio Details
    • 2.11.2 CCBio Major Business
    • 2.11.3 CCBio Self-administered Parenteral Product and Services
    • 2.11.4 CCBio Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 CCBio Recent Developments/Updates
  • 2.12 Phillips-Medisize Corporation
    • 2.12.1 Phillips-Medisize Corporation Details
    • 2.12.2 Phillips-Medisize Corporation Major Business
    • 2.12.3 Phillips-Medisize Corporation Self-administered Parenteral Product and Services
    • 2.12.4 Phillips-Medisize Corporation Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Phillips-Medisize Corporation Recent Developments/Updates
  • 2.13 Sorrel Medical
    • 2.13.1 Sorrel Medical Details
    • 2.13.2 Sorrel Medical Major Business
    • 2.13.3 Sorrel Medical Self-administered Parenteral Product and Services
    • 2.13.4 Sorrel Medical Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Sorrel Medical Recent Developments/Updates
  • 2.14 Krontec Healthcare
    • 2.14.1 Krontec Healthcare Details
    • 2.14.2 Krontec Healthcare Major Business
    • 2.14.3 Krontec Healthcare Self-administered Parenteral Product and Services
    • 2.14.4 Krontec Healthcare Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Krontec Healthcare Recent Developments/Updates
  • 2.15 Subcuject Aps
    • 2.15.1 Subcuject Aps Details
    • 2.15.2 Subcuject Aps Major Business
    • 2.15.3 Subcuject Aps Self-administered Parenteral Product and Services
    • 2.15.4 Subcuject Aps Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Subcuject Aps Recent Developments/Updates
  • 2.16 Ascendia Pharmaceuticals
    • 2.16.1 Ascendia Pharmaceuticals Details
    • 2.16.2 Ascendia Pharmaceuticals Major Business
    • 2.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
    • 2.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
  • 2.17 West Pharmaceutical Services, Inc.
    • 2.17.1 West Pharmaceutical Services, Inc. Details
    • 2.17.2 West Pharmaceutical Services, Inc. Major Business
    • 2.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
    • 2.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates

3 Competitive Environment: Self-administered Parenteral by Manufacturer

  • 3.1 Global Self-administered Parenteral Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Self-administered Parenteral Revenue by Manufacturer (2021-2026)
  • 3.3 Global Self-administered Parenteral Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Self-administered Parenteral by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Self-administered Parenteral Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Self-administered Parenteral Manufacturer Market Share in 2025
  • 3.5 Self-administered Parenteral Market: Overall Company Footprint Analysis
    • 3.5.1 Self-administered Parenteral Market: Region Footprint
    • 3.5.2 Self-administered Parenteral Market: Company Product Type Footprint
    • 3.5.3 Self-administered Parenteral Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Self-administered Parenteral Market Size by Region
    • 4.1.1 Global Self-administered Parenteral Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Self-administered Parenteral Consumption Value by Region (2021-2032)
    • 4.1.3 Global Self-administered Parenteral Average Price by Region (2021-2032)
  • 4.2 North America Self-administered Parenteral Consumption Value (2021-2032)
  • 4.3 Europe Self-administered Parenteral Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Self-administered Parenteral Consumption Value (2021-2032)
  • 4.5 South America Self-administered Parenteral Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Self-administered Parenteral Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 5.2 Global Self-administered Parenteral Consumption Value by Type (2021-2032)
  • 5.3 Global Self-administered Parenteral Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 6.2 Global Self-administered Parenteral Consumption Value by Application (2021-2032)
  • 6.3 Global Self-administered Parenteral Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 7.2 North America Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 7.3 North America Self-administered Parenteral Market Size by Country
    • 7.3.1 North America Self-administered Parenteral Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Self-administered Parenteral Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 8.2 Europe Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 8.3 Europe Self-administered Parenteral Market Size by Country
    • 8.3.1 Europe Self-administered Parenteral Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Self-administered Parenteral Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Self-administered Parenteral Market Size by Region
    • 9.3.1 Asia-Pacific Self-administered Parenteral Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Self-administered Parenteral Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 10.2 South America Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 10.3 South America Self-administered Parenteral Market Size by Country
    • 10.3.1 South America Self-administered Parenteral Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Self-administered Parenteral Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Self-administered Parenteral Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Self-administered Parenteral Market Size by Country
    • 11.3.1 Middle East & Africa Self-administered Parenteral Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Self-administered Parenteral Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Self-administered Parenteral Market Drivers
  • 12.2 Self-administered Parenteral Market Restraints
  • 12.3 Self-administered Parenteral Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Self-administered Parenteral and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Self-administered Parenteral
  • 13.3 Self-administered Parenteral Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Self-administered Parenteral Typical Distributors
  • 14.3 Self-administered Parenteral Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Self-administered Parenteral. Industry analysis & Market Report on Self-administered Parenteral is a syndicated market report, published as Global Self-administered Parenteral Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Self-administered Parenteral market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo